scispace - formally typeset
M

Masahiro Fukasaka

Researcher at Nitto Denko

Publications -  14
Citations -  194

Masahiro Fukasaka is an academic researcher from Nitto Denko. The author has contributed to research in topics: Osteoclast & Influenza vaccine. The author has an hindex of 6, co-authored 14 publications receiving 171 citations. Previous affiliations of Masahiro Fukasaka include Osaka University.

Papers
More filters
Journal ArticleDOI

The transcription factor Jdp2 controls bone homeostasis and antibacterial immunity by regulating osteoclast and neutrophil differentiation.

TL;DR: Jdp2 plays pivotal roles in in vivo bone homeostasis and host defense by regulating osteoclast and neutrophil differentiation and directly suppresses its expression via inhibition of histone acetylation.
Journal ArticleDOI

Mucosal vaccination using claudin-4-targeting

TL;DR: It is found that claudin-4 is expressed in nasal MALT, and OVA-C-CPE immunization activated both Th1 and Th2 responses, and nasal immunization showed anti-tumor activity in mice inoculated with Ova-expressing thymoma cells, indicating that the claudIn-4- targeting may be a potent strategy for nasal vaccination.
Journal ArticleDOI

Critical Role of AZI2 in GM-CSF–Induced Dendritic Cell Differentiation

TL;DR: TNFR-associated factor family member–associated NF-κB activator (TANK)–binding kinase 1 (TBK1) is critical for the activation of IFN regulatory factor 3 and type I IFN production upon virus infection but not TBK1-binding proteins, 5-azacytidine–induced gene 2 (AZI2), which can potentially be used to increase the efficiency of immunization by cDCs.
Journal ArticleDOI

A Lipopolysaccharide from Pantoea Agglomerans Is a Promising Adjuvant for Sublingual Vaccines to Induce Systemic and Mucosal Immune Responses in Mice via TLR4 Pathway.

TL;DR: It is suggested that LPSpa can be used as an effective mucosal adjuvant to stimulate and activate local innate immune cells to improve and enhance mucosal vaccine potency against various pathogens.